Involve clinicians in drug approval process: expert

A leading Canadian oncologist says Australia has plenty to learn from the way his country regulates cancer drug funding.

Dr Bill Evans (pictured), a former member of the Expert Review Committee of the pan-Canadian Oncology Drugs Review (pCODR), says one critical element to the approval process is the involvement of clinicians.

“We quite extensively involve clinicians in the evaluation of new drugs in Canada. Our cancer review